UltraSPECT
RELATED CONTENT
May 7, 2012 — Wide Beam Reconstruction (WBR) reduces the required radiopharmaceutical dose and image acquisition time by 50 percent for diagnostic quality myocardial perfusion imaging (MPI) single photon emission computed tomography (SPECT), according to a new study published in the March/April 2011 issue of the Journal of Nuclear Cardiology.
May 07, 2012 
August 23, 2011— UltraSPECT of Haifa, Israel, announced the sale of more than 10 of its wide beam reconstruction (WBR) software solutions to nuclear pharmaceutical supplier PCI for placement at customer medical facilities throughout Arizona. PCI is a member of United Pharmacy Partners Inc. (UPPI), a nuclear pharmacy network consortium that recently signed a multi-year distribution agreement for the leasing and/or non-exclusive sales of UltraSPECT’s cardiac and bone imaging applications in the United States.
August 23, 2011
May 31, 2011—UltraSPECT, a provider of nuclear medicine (NM) image reconstruction technology that reduces radiopharmaceutical dose and acquisition time, announces a multi-year distribution agreement with nuclear pharmacy network UPPI LLC for exclusive leasing and/or non-exclusive sale of UltraSPECT’s cardiac and bone imaging applications in the United States.
May 31, 2011
March 9, 2010 – As an alternative to the technetium (Tc-99M) isotope used in many nuclear imaging studies, UltraSPECT is advocating the use of thallium isotope (TI-201) imaging as an alternative.
March 09, 2010
June 8, 2009 – UltraSPECT announced today the addition of the half-dose imaging feature to the capabilities available on the Xpress.Cardiac, its half-time WBR image reconstruction product. This new feature can minimize radiation exposure to patients, maximizing safety for both patients and staff.
June 08, 2009